Class III

Drug Recall: NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03

Esperion · March 27, 2024

Reason for Recall

Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

3,480 30-count bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0441-2024

Status: completed

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Esperion Drug Recall: NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03 | SafeCheck